Replies to post #209428 on Biotech Values

[DewDiligence]

Re; NASH players

…players to watch out for besides ICPT and GILD…? Any thoughts on GALT, GLMD, or another company anyone?

If you take the position that FXR is the most “validated” NASH target, at least for early-stage disease, then you ought to include ENTA on your list. Please see #msg-128917063 for related info.